Legend Biotech Corp (LEGN)vsRevolution Medicines Inc (RVMD)
LEGN
Legend Biotech Corp
$28.12
-1.58%
HEALTHCARE · Cap: $5.28B
RVMD
Revolution Medicines Inc
$141.81
-0.49%
HEALTHCARE · Cap: $30.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Legend Biotech Corp generates 138566% more annual revenue ($1.03B vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -28.8%. LEGN earns a higher WallStSmart Score of 33/100 (F).
LEGN
Avoid33
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+22.3%
Fair Value
$23.87
Current Price
$28.12
$4.25 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 64.2% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
0.0% earnings growth
Weak financial health signals
ROE of -29.1% — below average capital efficiency
Negative free cash flow — burning cash
Trading at 17.1x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : LEGN
The strongest argument for LEGN centers on Revenue Growth. Revenue growth of 64.2% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Altman Z-Score.
Bear Case : LEGN
The primary concerns for LEGN are EPS Growth, Piotroski F-Score, Return on Equity.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
LEGN profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
LEGN is growing revenue faster at 64.2% — sustainability is the question.
LEGN generates stronger free cash flow (-127M), providing more financial flexibility.
Bottom Line
LEGN scores higher overall (33/100 vs 24/100) and 64.2% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Legend Biotech Corp
HEALTHCARE · BIOTECHNOLOGY · USA
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?